Dermapharm Holding SE (FRA:DMP) E10: €2.53 (As of Mar. 2026)


FRA:DMP Dermapharm Holding SE FRA:DMP
87 GF Score
Price €46.25
GF Value €39.11
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE E10?

Dermapharm Holding SE FRA:DMP 87 E10 is €2.53 as of Mar. 2026. GuruFocus rates FRA:DMP with a GF Score™ of 87/100 and a GF Value™ of €39.11 (Modestly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dermapharm Holding SE's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.840. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €2.53 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), Dermapharm Holding SE's current stock price is €46.25. Dermapharm Holding SE's E10 for the quarter that ended in Mar. 2026 was €2.53. Dermapharm Holding SE's Shiller PE Ratio of today is 18.28.

During the past 13 years, the highest Shiller PE Ratio of Dermapharm Holding SE was 19.70. The lowest was 14.19. And the median was 17.10.


Dermapharm Holding SE  (FRA:DMP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dermapharm Holding SE's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=46.25/2.53
=18.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Dermapharm Holding SE was 19.70. The lowest was 14.19. And the median was 17.10.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dermapharm Holding SE E10 Related Terms


Dermapharm Holding SE E10 Historical Data

* Premium members only.

The historical data trend for Dermapharm Holding SE's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE E10 Chart

Dermapharm Holding SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.47

Dermapharm Holding SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 2.47 2.53

FRA:DMP vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Shiller PE Ratio falls into.


FRA:DMP
87GF Score
Dermapharm Holding SE FRA:DMP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dermapharm Holding SE E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dermapharm Holding SE's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.84/131.2583*131.2583
=0.840

Current CPI (Mar. 2026) = 131.2583.

Dermapharm Holding SE Quarterly Data

per share eps CPI Adj_EPS
201412 0.000 99.543 0.000
201512 0.000 99.717 0.000
201612 1.229 101.217 1.594
201703 0.410 101.417 0.531
201706 0.390 102.117 0.501
201709 1.011 102.717 1.292
201712 0.277 102.617 0.354
201803 0.410 102.917 0.523
201806 0.310 104.017 0.391
201809 0.410 104.718 0.514
201812 0.280 104.217 0.353
201903 0.360 104.217 0.453
201906 0.380 105.718 0.472
201909 0.360 106.018 0.446
201912 0.340 105.818 0.422
202003 0.500 105.718 0.621
202006 0.220 106.618 0.271
202009 0.420 105.818 0.521
202012 0.450 105.518 0.560
202103 0.670 107.518 0.818
202106 0.740 108.486 0.895
202109 1.150 109.435 1.379
202112 1.330 110.384 1.582
202203 0.690 113.968 0.795
202206 0.270 115.760 0.306
202209 0.980 118.818 1.083
202212 0.550 119.345 0.605
202303 0.920 122.402 0.987
202306 -0.170 123.140 -0.181
202309 0.460 124.195 0.486
202312 -0.050 123.773 -0.053
202403 0.810 125.038 0.850
202406 0.320 125.882 0.334
202409 0.600 126.198 0.624
202412 0.380 127.041 0.393
202503 0.620 127.779 0.637
202506 0.390 128.412 0.399
202509 0.760 129.255 0.772
202512 0.690 129.361 0.700
202603 0.840 131.258 0.840

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €2.53 mean?
Dermapharm Holding SE (FRA:DMP) has a E10 of €2.53 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dermapharm Holding SE and its competitors.
Is Dermapharm Holding SE's E10 too high?
Dermapharm Holding SE's current E10 is €2.53. Overall, Dermapharm Holding SE has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's E10 compare to ZTS and UTHR?
Dermapharm Holding SE's E10 of €2.53 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Dermapharm Holding SE and its competitors. Dermapharm Holding SE's current E10 is €2.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Based on GuruFocus' analysis, Dermapharm Holding SE (FRA:DMP) is currently considered Modestly Overvalued. The stock's GF Value™ is €39.11, compared to a current price of €46.25 — trading 18.3% above its estimated fair value. The current E10 is €2.53. Dermapharm Holding SE's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Dermapharm Holding SE (FRA:DMP), the current E10 is €2.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11. GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.

Key valuation signals for FRA:DMP:

  • E10: €2.53
  • GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dermapharm Holding SE Business Description

Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score

Get the complete analysis for FRA:DMP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.25
Price
€39.11
GF Value